Business Description
Eurobio Scientific
ISIN : FR0013240934
Share Class Description:
XPAR:ALERS: Bearer and/or Registered shares issued from reverse splitCompare
Compare
Traded in other countries / regions
ALERS.FranceE8TN.GermanyDXNHF.USA IPO Date
2005-11-17Description
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.66 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | 4.23 | |||||
| Interest Coverage | 16.11 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.68 | |||||
| Beneish M-Score | -1.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.2 | |||||
| 3-Year EBITDA Growth Rate | 81.1 | |||||
| 3-Year EPS without NRI Growth Rate | 100.1 | |||||
| 3-Year FCF Growth Rate | 135.1 | |||||
| 3-Year Book Growth Rate | 73.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.99 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.9 | |||||
| 9-Day RSI | 28.89 | |||||
| 14-Day RSI | 31.95 | |||||
| 6-1 Month Momentum % | 0.9 | |||||
| 12-1 Month Momentum % | -4.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.12 | |||||
| Quick Ratio | 2.7 | |||||
| Cash Ratio | 1.61 | |||||
| Days Inventory | 97.61 | |||||
| Days Sales Outstanding | 64.7 | |||||
| Days Payable | 48.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3.1 | |||||
| Shareholder Yield % | -61.68 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.35 | |||||
| Operating Margin % | 31.79 | |||||
| Net Margin % | 4.69 | |||||
| FCF Margin % | 14.35 | |||||
| ROE % | 4.59 | |||||
| ROA % | 2.76 | |||||
| ROIC % | 22.56 | |||||
| ROC (Joel Greenblatt) % | 35.47 | |||||
| ROCE % | 5.65 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.17 | |||||
| PE Ratio without NRI | 3.81 | |||||
| Shiller PE Ratio | 27.09 | |||||
| Price-to-Owner-Earnings | 3.58 | |||||
| PS Ratio | 0.89 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 7.05 | |||||
| Price-to-Free-Cash-Flow | 6.27 | |||||
| Price-to-Operating-Cash-Flow | 5.22 | |||||
| EV-to-EBIT | 13.52 | |||||
| EV-to-EBITDA | 7.26 | |||||
| EV-to-Revenue | 1.09 | |||||
| EV-to-FCF | 7.79 | |||||
| Price-to-Projected-FCF | 0.32 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 1.08 | |||||
| Earnings Yield (Greenblatt) % | 7.39 | |||||
| FCF Yield % | 16.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurobio Scientific Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 168.55 | ||
| EPS (TTM) (€) | 0.774 | ||
| Beta | 0.27 | ||
| Volatility % | 26.11 | ||
| 14-Day RSI | 31.95 | ||
| 14-Day ATR (€) | 0.478941 | ||
| 20-Day SMA (€) | 15.505 | ||
| 12-1 Month Momentum % | -4.94 | ||
| 52-Week Range (€) | 12.2 - 18.1 | ||
| Shares Outstanding (Mil) | 10.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurobio Scientific Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurobio Scientific Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eurobio Scientific Frequently Asked Questions
What is Eurobio Scientific(XPAR:ALERS)'s stock price today?
The current price of XPAR:ALERS is €14.46. The 52 week high of XPAR:ALERS is €18.10 and 52 week low is €12.20.
When is next earnings date of Eurobio Scientific(XPAR:ALERS)?
The next earnings date of Eurobio Scientific(XPAR:ALERS) is .
Does Eurobio Scientific(XPAR:ALERS) pay dividends? If so, how much?
Eurobio Scientific(XPAR:ALERS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers